Test shows efficacy in detecting neuropathy in diabetes

05/6/2013 | Healio

A study presented at the American Association of Clinical Endocrinologists annual meeting found diabetes patients with neuropathy showed worse electrochemical skin conductance, as measured by the FDA-approved Sudoscan test, than those who did not have neuropathy. Researchers said the test may be useful for early diagnosis of diabetic neuropathy and for evaluation of responses to therapeutic interventions.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY